Results for tag: "Fixed Dose Combination Drug"

The Fixed Dose Combination Drug (FDC) market is a segment of the pharmaceutical industry that focuses on the development and production of drugs that combine two or more active ingredients in a single dosage form. FDCs are designed to provide a more convenient and cost-effective way to treat multiple conditions with a single medication. FDCs are also used to reduce the risk of drug interactions and to improve patient compliance. FDCs are regulated by the Food and Drug Administration (FDA) and must meet the same safety and efficacy standards as single-ingredient drugs. The FDA also requires that FDCs be labeled with information about the active ingredients, dosage form, and potential side effects. Some of the major players in the FDC market include Pfizer, GlaxoSmithKline, Merck, Novartis, and Sanofi. These companies have a wide range of FDCs available, including treatments for cardiovascular disease, diabetes, and infectious diseases. Show Less Read more